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Upregulation of MMP12 and Its Activity by UVA1
in Human Skin: Potential Implications for Photoaging
Angela Tewari1, Katarzyna Grys2, Jutta Kollet3, Robert Sarkany1 and Antony R. Young1
UVA1 constitutes around 75% of the terrestrial UV radiation, and most of the output of artificial tanning sources.
However, the molecular effects of UVA1 in human skin in vivo are surprisingly poorly understood. We have
examined time-dependent whole-genome expression, along with mRNA and protein changes in the skin after
one minimal erythema dose of spectrally pure UVA1 (50 J cm 2) and 300nm UVB (30mJ cm 2). After 24hours, the
genes induced to the greatest extent were those involved in extracellular matrix remodeling with both UVA1
(P¼ 5.5e 7) and UVB (P¼ 2.9e 22). UVA1 and UVB caused different effects on matrix metalloproteinase (MMP)
expression: UVB induced MMP1, MMP3, and MMP10 mRNA at 24hours to a much greater extent than UVA1.
MMP12 induction by UVA1 at 6hours is marked and much greater than that by UVB. We have found that MMP12
mRNA induction by UVA1 resulted in expression of MMP12 protein, which is functional as an elastase. This
induction of elastase activity did not occur with UVB. We hypothesize that the UVA1 induction of MMP12
mediates some of its photoaging effects, particularly by contributing to elastin degeneration in late solar elastosis.
MMP12 is a good marker of UVA1 exposure.
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INTRODUCTION
Terrestrial solar UV radiation (UVR) comprises o5% UVB
(B295–315 nm) and 495% UVA (315–400 nm), the
majority (B75%) of which is UVA1 (340–400 nm). UVA1
also makes up most (B80%) of the spectral output of sunbeds
and is used at high doses as a specialist form of photo-
therapy (Kerr et al., 2012). However, the acute effects of
UVA1 in vivo, including its effects on gene expression, are
much less well understood than those of UVB (Enk et al.,
2004; Enk et al., 2006). As it is now clear that UVA1 is
biologically active and mutagenic in human skin in vivo
(Mouret et al., 2006; Tewari et al., 2012), it is clinically
important to understand the biological effects of UVA1 in the
skin. Previous studies on the effects of UVA1 on whole-
genome expression in vivo have been limited and have
primarily focused on understanding mechanisms of pigmenta-
tion (Choi et al., 2010).
The hallmarks of long-term exposure to solar UVR are
photoaging (Yaar and Gilchrest, 2007) and photocarcino-
genesis (Sage et al., 1996). Photoaging is characterized by
the induction of extracellular matrix-degrading proteolytic
enzymes (matrix metalloproteinases, MMPs) without a
parallel induction of inhibitors of proteolysis (tissue inhibitor
of metalloproteinases). The resulting pathological remodeling
process involves the degradation of collagen and the
accumulation of abnormal elastin in the superficial dermis,
resulting in the characteristic changes of solar elastosis (Chen
et al., 1986; Uitto, 2008). Previous studies with UVR sources
rich in UVB showed induction of MMP1, MMP3, and MMP9
mRNA (Brenneisen et al., 1996; Fisher et al., 1996; Fisher
et al., 1997) in human skin in vivo. UVA sources have also
been reported to induce MMP1 expression in fibroblasts
(Scharffetter et al., 1991; Herrmann et al., 1993). There are
few data on the effects of spectrally pure UVA1 on MMPs in
human skin in vivo (Wang et al., 2013).
MMP activity is required both in normal physiological pro-
cesses such as wound healing and angiogenesis (Chakraborti
et al., 2003) and in the pathological tissue destruction that
occurs in chronic wounds, dermal photoaging, bullous skin
disease, cancer invasion, and metastasis (Kerkela and
Saarialho-Kere, 2003). The mechanisms by which UVR
induces MMPs are poorly understood. Some studies have
reported that this occurs via the generation of reactive oxygen
species (Scharffetter-Kochanek et al., 1993; Fisher et al.,
2009), whereas others have suggested that DNA is a major
chromophore and that MMPs are triggered by the formation of
cyclobutane pyrimidine dimers (CPDs) (Dong et al., 2008).
MMPs may also be induced by mediators such as tumor
necrosis factor a (Steenport et al., 2009), which is also readily
induced in the skin by UVR, probably via the induction of
ORIGINAL ARTICLE
1King’s College London, King’s College London School of Medicine, Division
of Genetics and Molecular Medicine, St John’s Institute of Dermatology,
London, UK; 2St John’s Institute of Dermatology, NIHR GSTFT/KCL Biomedical
Research Centre, Guy’s Hospital, London, UK and 3Bioinformatics, Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany
Correspondence: Angela Tewari, King’s College London, King’s College
London School of Medicine, Division of Genetics and Molecular Medicine,
St John’s Institute of Dermatology, London, UK. E-mail: angela.tewari@kcl.ac.uk
Received 9 April 2013; revised 22 February 2014; accepted 11 March 2014;
accepted article preview online 8 April 2014; published online 8 May 2014
Abbreviations: MMP1, matrix metalloproteinase 1; MMP12, matrix
metalloproteinase 12; UVA1, ultraviolet A1 (340–400nm)
2598 Journal of Investigative Dermatology (2014), Volume 134 & 2014 The Society for Investigative Dermatology
CPDs (Walker and Young, 2007) and IL6 (Wlaschek et al.,
1994).
It is widely considered that UVA has a larger role than UVB
in photoaging, both because of the deeper penetration of
UVA into the dermis (Bruls et al., 1984) and because of
the sensitivity of fibroblasts to UVA-induced MMPs
(Scharffetter et al., 1991; Herrmann et al., 1993). There are
inherent problems with previous studies that relate to spectral
purity of the source of UVR. UVB sources often also emit a
considerable amount of UVA and it is not possible to attribute
an effect to UVB without knowledge of the action spectrum of
the end point under investigation. Even minor contamination
of a nominal UVA source with very small amounts of UVB
may give misleading results because o1% UVB
contamination can be responsible for most of a given effect,
e.g., DNA damage (Woollons et al., 1999). Also, UVA2 (315–
340 nm) and UVA1 are biologically and mechanistically
different. Thus, we have concentrated our studies on the
biological effects of spectrally pure UVB (300 nm) and UVA1.
In a recent work, we reported that solar UVB exposure was
probably the most important factor in MMP1 induction from
an environmentally relevant perspective (Tewari et al., 2012).
In this study, we compare the effects in vivo of erythemally
equivalent and biologically relevant doses of spectrally pure
UVA1 and UVB on whole genome expression, mRNA, and
protein and enzyme activity of the most significantly enriched
pathway at 24 hours (extracellular matrix remodeling). We
have used this approach because erythema is the widely used
end point in clinical and experimental photodermatology. We
chose 300 nm because it is in the region of the peaks of the
action spectra both for erythema and for CPD induction in
human skin in vivo (Young et al., 1998) and its photo-
biological effects are likely to be mechanistically different
from UVA1. Furthermore, erythemal exposure, quantified
by the standard erythema dose, is increasingly used as a
measure of UVR exposure in clinical and epidemiological
studies.
RESULTS
Extracellular matrix remodeling genes are induced to a greater
extent than other pathways, both by UVA1 and by UVB 24hours
after exposure.
We used Genego Metacore v7 on our microarray data to
identify upregulated pathways at 6 and 24 hours using the
pooled intensities (n¼9 for UVA1 and n¼5 for UVB) of
upregulated genes compared with each individual’s nonirra-
diated control (Po0.05, fold change X2). At 6 hours, the most
significantly enriched pathway was inflammation through
Th17 signaling for erythemally equivalent doses of UVA1
(P¼ 1.16e6) and UVB (P¼ 2.1e4). At 24 hours, the most
significantly enriched pathway was extracellular matrix remo-
deling for UVA1 (P¼5.5e7) and UVB (P¼2.9e22).
Many other groups of genes were induced to lesser extents
but this paper will focus on the MMPs, given their striking
degree of induction.
Whole-skin microarray analysis at 6 (Figure 1a) and
24 hours (Figure 1b) after exposure indicated that genes
encoding MMP1, MMP3, MMP9, MMP10, and MMP12 are
induced predominantly at 24 hours. MMP1, MMP3, and
MMP10 (10–550-fold, Pp0.05, adjusted Pp0.3) were
induced to a greater extent by UVB, whereas UVA1 induced
a 15-fold increase in MMP12 gene expression at 6 hours
(Pp0.05, adjusted Pp0.3) that increased to around 30-fold at
24 hours (Pp0.05, adjusted Pp0.3).
Key UVA1 and UVB mRNA expression differences
Specific genes assessed by reverse transcription quantitative
PCR (qPCR) at 6 and 24 hours are shown in Figure 1c–h.
At 24 hours, UVB was more effective than UVA1 at inducing
MMP1 (P¼ 0.0062, UVB/UVA1 fold difference 13.2)
(Figure 1c), MMP3 (P¼0.0016, UVB/UVA1 fold difference
38.7) (Figure 1d), and MMP10 (P¼ 0.028, UVB/UVA1 fold
difference 27.1) (Figure 1e). Both UVA1 and UVB induce
MMP9 mRNA to an equal extent (at 6 and 24 hours post
exposure (Figure 1f); P¼0.33 at 6 hours, P¼0.12 at 24 hours).
UVA1 was more effective than UVB at inducing MMP12
mRNA at 6 (P¼0.02, UVA1/UVB fold difference 19.2) and
24 hours (P¼0.22, UVA1/UVB fold difference 8.26). How-
ever, the large interindividual variation at 24 hours means that
the difference is not significant (Figure 1g). UVA1 did not
induce MMP3 or MMP10.
UVR-induced MMP1 protein and its activity in the epidermis
Typical MMP1 and MMP12 protein staining (red fluorescence)
and enzyme activity (in situ zymography shown by green
fluorescence) are shown in Figure 2a and b, respectively.
UVB and UVA1 induce MMP1 protein (at 10 and 24 hours
(Figure 2c)) to a similar extent. Enzyme activity is preferentially
induced by UVB at 24 hours compared with UVA1 (P¼ 0.031)
(Figure 2d). DQ collagen type I is a substrate for MMP1,
MMP2, MMP3, MMP9, and MMP13 (Yan and Blomme, 2003).
Figure 3a shows that MMP2 protein was not induced by either
spectrum at 24 hours. However, as shown in Figure 3b, UVB
induced an increase in MMP9 protein at 24 hours.
UVA1 preferentially induces MMP12
MMP12 protein is predominantly formed by UVA1 at 24 hours
(P¼ 0.04) (Figure 2e). A lesser degree of induction of MMP12
protein is seen with UVB at 10 and 24 hours, despite the
absence of MMP12 mRNA induction by UVB at 6 and 24hours.
There is significantly (P¼ 0.027) more MMP12 activity at
10 hours after UVA1 exposure than after UVB (Figure 2f).
Location of MMP1 and MMP12 proteins within the epidermis
Figure 2g and h show that MMP1 protein is mainly induced
in the upper epidermis (upper versus lower epidermis UVB
P¼0.005 and UVA1 P¼0.01), whereas MMP12 is equally
induced throughout the epidermis (Figure 2i and j) (upper vs.
lower epidermis UVB P¼ 0.20, UVA1 P¼ 0.42).
UVR-induced MMPs and their activity in the dermis
Expression of MMP1 and MMP12 proteins in the dermis are
higher with UVA1 than UVB (Figure 4a and c), but there are
no spectral differences in the enzyme activities (Figure 4b
and d). Overall, both MMP protein and enzyme activity are
higher in the epidermis than in the dermis. Figure 5a shows
A Tewari et al.
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Figure 1. Key UVA1 and UVB gene expression differences in extracellular matrix remodeling: RNA changes. Nine skin type I/II participants for UVA1
and five skin type I/II participants for UVB, RNA extracted and converted to cRNA, and hybridized to Agilent 4 44 K microarray chips. Normalized gene
expression ratios (log2) compared with each individual’s nonirradiated control at (a) 6 hours and (b) 24 hours were used for calculations. The individual values were
plotted (Pp0.05, adjusted Pp0.3). Validation with reverse transcriptase (RT) quantitative (PCR) qPCR (DDCT method) using Taqman probes and
GAPDH housekeeping gene to produce a relative fold change: (c) MMP1, (d) MMP3, (e) MMP10, (f) MMP9, (g) MMP12, (h) MMP13. *Pp0.05, **Pp0.01.
Microarray and qPCR were performed on samples from all nine volunteers.
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that UVA1, but not UVB, induces elastin breakdown in the
epidermal region.
Macrophages are a potential source of UVA1-induced MMP12
Figure 5b shows significant depletion of dermal macrophages
(CD68þ ) 24 hours after UVB exposure. In contrast, UVA1 had
no effect on dermal macrophage numbers (P¼0.21) com-
pared with nonirradiated controls.
DISCUSSION
We have compared UVR-induced MMPs using spectrally pure
UVB (300 nm) and UVA1 on the same individuals, which is
likely to reduce the impact of interpersonal variation. Our
UVA1 doses are physiologically relevant; 50 J cm 2 would
be a typical dose received from a 2.5 hour exposure to the
tropical Australian sun (19 1S) (Bernhard et al., 1997) and
higher doses are regularly given for treatment of sclerosing
skin conditions (Kerr et al., 2012).
Baseline expression of MMPs is usually low in human
tissue, including skin. Our gene array data (supported by
qPCR) show that erythemally equivalent doses of UVB and
UVA1 induce many MMPs. There was no increase in tissue
inhibitor of metalloproteinases 1–4 with either spectrum
assessed by microarray (data not shown). For most MMPs,
induction by UVB peaked at 24 hours, although some expres-
sion is seen at 6 hours with some MMPs. MMP12 gene and
mRNA expression by UVA1 is seen at 6 hours but primarily at
24 hours. The most striking fold increases with UVB were for
MMP1 and MMP3 with array and qPCR technology. There
was also an impressive increase of MMP10 mRNA with qPCR.
Neither UVB nor UVA1 had any effect on MMP2 assessed
by microarray, mRNA (data not shown), and protein. The most
striking effect of UVA1 was on MMP12, as assessed by the
three techniques. In contrast, UVB had little effect on MMP12
expression. There was modest or no evidence of any UVA1
induction of MMP3 or MMP10 by qPCR. MMP12 mRNA
expression has been reported in human skin in vivo at 16 and
24 hours by others (Chung et al., 2002), after a 2 minimal
erythema dose (MED) exposure from a broad-spectrum
UVB–UVA source. In another study, no MMP12 mRNA was
Unirradiated
MMP1 DAPI
MMP12 DAPI
DQ1 DAPI
DQ4 DAPI
UVA1 10 hours UVB 10 hours UVA1 24 hours UVB 24 hours
Unirradiated UVA1 10 hours UVB 10 hours UVA1 24 hours UVB 24 hours
Figure 2. UVA1 induces more epidermal matrix metalloproteinase (MMP)12 protein (immunofluorescence) and enzyme activity (in situ zymography)
than UVB. MMP1 and MMP12 protein (antibodies from Abcam) immunofluorescence in one representative individual detected by (a) alexafluor 555
(red fluorescence) for 30 mJ cm2 UVB (B1 minimal erythema dose (MED)) at 10 and 24 hours and 50 J cm2 (B1MED) of UVA1 at 10 and 24 hours and
(b) DQ collagen type I (DQ1), substrate for MMP1, MMP2, and MMP9, and DQ collagen type IV (DQ4), substrate for MMP2, MMP7, MMP9, MMP12,
and MMP25, were used to detect enzyme activity via fluorescein (green fluorescence), quantification of (c) epidermal MMP1, (d) epidermal DQ1,
(e) epidermal MMP12, and (f) epidermal DQ4. Distribution of MMP1 and MMP12 within the epidermis, (g) UVB-induced MMP1, (h) UVA1-induced MMP1,
(i) UVB-induced MMP12, and (j) UVA1-induced MMP12. *Pp0.05, **Pp0.01; n¼ 3. Scale bar¼50mm.
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detected after exposure to UVA1 or broad-spectrum UVR
(UVB with UVA) for three consecutive days (Saarialho-Kere
et al., 1999).
Recently, it was shown that 40 J cm2 UVA1 in human skin
in vivo increased MMP1 and MMP3 mRNA byB80- and 50-
fold, respectively, at 24 hours (Wang et al., 2013). These data
are comparable to the responses we see to 50 J cm2 UVA1
(especially for MMP3), which are 25- and 45-fold compared
to nonirradiated control tissue for MMP1 and MMP3,
respectively (see Figure 1c and d), given the error range in
both data sets. Repeated (4 ) low-dose UVA1 on human skin
in vivo results in an accumulation of MMP1 and MMP3
mRNA expression (Wang et al, 2013).
Our protein studies show that UVR-induced MMPs are
predominantly expressed in the epidermis, which is expected
because of their role in epithelial tissue homeostasis after UVR
Epidermal MMP12 Epidermal DQ4
UVB MMP1 UVA1 MMP1
UVB MMP12 UVA1 MMP12
10 Hours
UVA1
10 Hours
UVB
24 Hours
UVA1
24 Hours
UVB
0
25
50
75
*
10 Hours
UVA1
10 Hours
UVB
24 Hours
UVA1
24 Hours
UVB
0
10
20
30
40 *
0
50
100
150
**
0
50
100
150
*
0
10
20
30
40
50
60
70
0
10
20
30
40
50
60
70
Epidermal MMP1 Epidermal DQ1
10 Hours
UVA1
10 Hours
UVB
24 Hours
UVA1
24 Hours
UVB
0
25
50
75
M
ea
n 
in
te
ns
ity
 c
on
tro
l ±
 S
EM
M
ea
n 
in
te
ns
ity
 c
on
tro
l ±
 S
EM
M
ea
n 
in
te
ns
ity
 ±
 S
EM
M
ea
n 
in
te
ns
ity
 ±
 S
EM
M
ea
n 
in
te
ns
ity
 ±
 S
EM
M
ea
n 
in
te
ns
ity
 ±
 S
EM
M
ea
n 
in
te
ns
ity
 c
on
tro
l ±
 S
EM
M
ea
n 
in
te
ns
ity
 c
on
tro
l ±
 S
EM
10 Hours
UVA1
10 Hours
UVB
24 Hours
UVA1
24 Hours
UVB
0
10
20
30
40
*
Treatment
Treatment Treatment
Treatment
Upper epidermis Lower epidermis Upper epidermis Lower epidermis
Upper epidermis Lower epidermis Upper epidermis Lower epidermis
Figure 2. Continued.
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injury. Other studies support this observation (MMP1, MMP3,
and MMP9 mRNA and MMP1 activity) after exposure to
solar-simulating radiation (Quan et al, 2009). However, we
believe that our data demonstrate MMP1 protein/activity by
spectrally pure UVB and UVA1.
There are eight elastases in human skin (Liang et al., 2006),
of which human macrophage elastase (HME) or MMP12
(Shapiro, 1998; Shapiro et al., 1993), and neutrophil-derived
(neutrophil elastase (NE)) are induced by UVR (Lee et al.,
2008). NE has long-term photobiological significance,
because NE-deficient mice are resistant to photoaging
(Starcher and Conrad, 1995; Takeuchi et al., 2010) and
squamous cell carcinoma formation (Starcher et al., 1996)
after exposure to a source containing 10% UVB and 90%
UVA. This suggests that elastase may be linked to these two
long-term consequences of UVR exposure.
MMP12 protein has been detected in ‘‘a few stromal
fibroblast/macrophage-like cells’’ after exposure to UVA1
(Saarialho-Kere et al., 1999). A modest induction of dermal
fibroblast MMP12 (but not in macrophages) has also been
reported in human skin in vivo after a 2 MED exposure from
a broad-spectrum UVB–UVA source (Chung et al., 2002;
Saarialho-Kere et al., 1999). UVB induced significantly greater
(P¼ 0.02) depletion of papillary dermal macrophages than did
UVA1 (Figure 5b). Thus MMP12 could be explained by the
larger presence of activated macrophages in the dermis after
UVA1. MMP12-negative macrophages cannot penetrate the
dermal/epidermal junction (Shipley et al., 1996), and we
found no evidence of epidermal macrophages. We did not
stain for NE, but dermal neutrophil infiltration (and likely NE
release) is a predominantly UVB-driven process (Lee et al.,
2008) and is therefore unlikely to explain our UVA1 data.
MMP12 is also produced by activated T cells (Hughes et al.,
1998), transformed keratinocytes, and keratinocyte-derived
tumors (Kerkela et al., 2000). Given that we found MMP12
primarily in the epidermis, irrespective of spectrum, we
suggest that it is mainly derived from normal keratinocytes.
However, we cannot exclude the possibility that some
MMP12 may be derived from dermal cells such as
fibroblasts and macrophages.
UVB and UVA1 induced the degradation of DQ collagen
type I. The assessment of specific MMP function by in situ
zymography is complicated by cross-reactivity. DQ collagen
type I is primarily a substrate for MMP1 but is also degraded
by MMP2, MMP3, MMP9, and MMP13 (Yan and Blomme,
2003). There is no UVR induction of MMP2 mRNA or protein
(Figure 3a) at 24 hours but there is a small (B20%) significant
increase in MMP9 protein by UVB (Figure 3b). This has been
previously reported (as 92 kd gelatinase) (Fisher et al., 1997)
with a broad-spectrum UVB–UVA source. As UVB and UVA1
induce MMP13 mRNA to similar extents (Figure 1h), it is
possible that the UVB-induced collagen I hydrolytic activity is
also mediated via MMP3 and MMP9. We did not measure
MMP3 protein, but UVB resulted in a very large increase in its
mRNA that was not seen with UVA1. However, MMP3
protein (stromelysin-1) has been shown to increase after
exposure to a UVB–UVA source (Fisher et al., 1997).
UVA1 was more effective than UVB for the degradation of
DQ collagen type IV in the epidermis (10 hours). This is
primarily a substrate for MMP12, but it is also hydrolyzed by
MMP2, MMP7, MMP9, and MMP25 (Yan and Blomme,
2003). As MMP2, MMP7, MMP9, and MMP25 mRNAs were
not induced by UVA1, the induction of enzyme activity is
more likely to reflect the induction of MMP12. This is also
supported by the lack of UVA1 effects on MMP2 and MMP9
protein expression. There is some collagen IV hydrolysis with
UVB at 10 and 24 hours that could be due to UVB-induced
MMP9 (Figure 3b), although without MMP12-blocking
enzymes we cannot rule out the effects of MMP12.
UVB was significantly more effective than UVA1 at indu-
cing epidermal MMP1 activity at 24 hours. In contrast, UVA1
was more potent at induction of epidermal MMP12 protein
(24 hours) and its activity (10 hours) against DQ collagen type
IV. It was also significantly better at the induction of dermal
MMP1 and MMP12 proteins at 24 hours. This difference is
likely to be due to greater UVA1 dermal penetration/scattering
(Tewari et al., 2011; Tewari et al., 2012). Interestingly,
we found no spectral differences for dermal MMP1 and
MMP12 activity against their respective collagen substrates,
but there was large interpersonal variation. There was some
UVB-induced MMP12 protein, predominantly in the
epidermis, but to a much lesser extent than with UVA1.
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The small amount (relative to epidermis) of UVA1-induced
MMP12 in the dermis, maybe insufficient to degrade elastin at
24 hours because no elastase activity was detected in the
dermal region, although this was considerable in the epider-
mal region. This may be attributed to greater MMP12 protein
induction in the epidermis. This is also supported by the in situ
zymography data for degradation of collagen IV. Essentially,
the degradation of two substrates by MMP12 was an epider-
mal phenomenon in which UVA1 was more effective
than UVB.
Dermal extracellular collagens are degraded in photoaging.
Quan et al (2009) have suggested that epidermal MMP1,
MMP3, and MMP9 (where they report the majority is
synthesized), diffuse into the dermis to degrade collagen
(Quan et al., 2009). However, studies on photoaged skin
show more MMPs in the dermis than in the epidermis (Chung
et al., 2002; Quan et al., 2013). Overall, this suggests that
repeated solar UVR exposure results in an accumulation of
dermal MMP, whether by diffusion from the epidermis or by a
gradual accumulation of dermally synthesized protein. It is
also possible that our 24-hour sampling time was not optimal
for MMP12 diffusion from the epidermis into the dermis and
the degradation of elastin.
Light microscopy shows that the papillary dermis of photo-
aged skin contains an accumulation of amorphous
disorganized elastin fibrils, which is known as ‘‘solar elasto-
sis’’ (Calderone and Fenske, 1995; Yaar and Gilchrest, 2007).
In its early stages, there is an accumulation of insoluble disor-
ganized elastin and microfibrillar proteins (fibronectin) (Chen
et al., 1986; Lavker and Kligman, 1988), seen clinically as
waxy, thickened, and furrowed facial skin. In more advanced
solar elastosis, degeneration of dermal elastin results in a
mottled appearance that is clinically associated with a loss of
skin elasticity. The addition of an elastase to an elastin culture
(Braverman and Fonferko, 1982) results in a mottled
appearance that is similar to that seen in late solar elastosis.
This appearance, termed ‘‘zebra bodies’’, can also be induced
by repeated erythemal doses of UVA, but not by solar-
simulated radiation (Kumakiri et al., 1977).
Our data with gene array, qPCR, and protein activity
strongly suggest that UVA1 preferentially induces MMP12.
We acknowledge that our protein studies are based on small
sample sizes (n¼3). However, they generally correlate with
the mRNA data, and the protein expression and activity data
are mutually consistent. Our elastase activity data (Figure 5)
are particularly striking. MMP12 protein has been observed in
the upper dermis of patients with solar elastosis and actinic
keratosis (Saarialho-Kere et al., 1999; Chung et al., 2002).
Chung et al. (2002) suggest that MMP12 has a role in elastin
remodeling in solar elastosis of the face. We suggest that solar
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elastosis, and its association with MMP12, may be explained
by our studies because MMP12 is the major enzyme for the
degradation of elastin (Gronski et al., 1997; Woessner, 1991).
However, we cannot exclude other MMPs having a role in the
pathogenesis of solar elastosis, because MMP2, MMP7, and
MMP9 also have elastolytic activity and may be induced by
UVB (e.g., MMP9 as shown in Figure 3b). In addition, MMP12
degrades other substrates apart from type IV collagen includ-
ing laminin 1, fibronectin, vitronectin, and proteoglycans
(Gronski et al., 1997).
We hypothesize that solar UVA1 induces the expression of
MMP12, which then degrades elastin, contributing to the loss
of skin elasticity seen in late solar elastosis. This may occur, as
suggested by Quan et al (2009), by diffusion of the MMPs
from the epidermis to the upper dermis. The resultant loss
of elasticity, termed ‘‘sagging’’, has been shown to be a
UVA1-dependent process in hairless mice, with an action
spectrum peak at 340 nm (Bissett et al., 1987, 1989). This
suggests that UVA1 has important implications for photoaging
and also possibly photocarcinogenesis (Starcher and Conrad,
1995; Starcher et al., 1996). This is supported by studies
that show that people habitually exposed to UVA through
glass on one side of the face show more signs of photoaging
and skin cancer on the exposed side (Butler and Fosko,
2010; Foley et al., 1986; Mac-Mary et al., 2010; Singer
et al., 1994).
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A reduction of photoaging in an intense solar environment
has been observed with the long-term discretionary use of a
sunscreen (SPF 15þ )(Hughes et al., 2013). Its formulation is
not photostable, and would have lost most of its UVA1
protection within 1 hour (Dr B Herzog, personal commu-
nication). Our MMP12 data support the inclusion of good
photostable UVA1 protection in sunscreens to enhance their
ability to inhibit photoaging. Furthermore, our data suggest
that the inhibition of MMP12 may be a future strategy for
protecting against photoaging.
The absorption of UVR by chromophores mediates all
photobiological reactions. UVB absorbed by DNA results in
CPD formation, the action spectrum of which peaks at 300 nm
in human skin in vivo (Young et al., 1998). There is evidence
that DNA is a chromophore for MMP1 via CPD formation
(Dong et al., 2008). Our recent findings (Tewari et al., 2012;
Tewari et al., 2011) showed considerable attenuation of UVB-
induced CPDs with skin (epidermis and dermis) depth, which
was not the case with UVA1. Thus, we would expect to see
marked attenuation of UVB-induced MMP1 with skin depth,
as shown in Figures 2g and 4a, if DNA were the putative
chromophore. In contrast, epidermal depth has no effect on
the distribution of MMP12 induced by UVB or UVA1
(Figure 2i and j). This suggests that they have different
chromophores. We therefore propose that UVA1 induces
MMP12 via a non-DNA chromophore that generates reactive
oxygen species (Scharffetter-Kochanek et al., 1993; Wlaschek
et al., 1995). This is supported by studies that showed that
topical reactive oxygen species scavengers reduced MMP12
mRNA in human skin (Chung et al., 2002). UVA1 did not
induce MMP3 or MMP10 when assessed by qPCR. Our
erythemal dose of UVA1 (50 J cm2) does induce CPDs,
although at one-fourth to one-third times lower levels than
after an erythemally equivalent exposure to UVB (Tewari,
Sarkany et al., 2011). This suggests that these enzymes may
not only have a CPD threshold but may also have non-DNA
chromophores that are required for their induction.
MATERIALS AND METHODS
Volunteers
The studies were approved by the St Thomas’ Hospital, London, UK
Ethics Committee (Ref: 09/H0802/98) in accordance with the declara-
tion of Helsinki. The details of the 12 healthy skin type I/II volunteers
are shown in Table 1. Participants gave written informed consent
before taking part in the study.
Irradiation
UVR sources, dosimetry, and irradiation protocol. Emission
spectra and irradiances of the UVA1 and UVB sources, and
assessment of MED are previously described (Tewari et al., 2011).
Table 1 shows that the mean MEDs for 12 volunteers were
29.2±5.8 mJ cm 2 (UVB) and 58.6±7.9 J cm 2 (UVA1).
Experimental protocol. (i) ‘‘UVA1 time course’’: four skin type
I/II volunteers were irradiated over a 1-cm2 area on previously
unexposed buttock skin with 50 J cm 2 UVA1 and 4-mm punch
biopsies were taken under local anesthesia 6 and 24 hours later.
This wasB1MED (minimal erythema dose) and was based on our
previous work (Tewari et al., 2011). (ii) ‘‘UVA1 and UVB
comparison’’: five skin type I/II participants were exposed to
50 J cm 2 UVA1 and 30 mJ cm 2 (B1MED) UVB and biopsies
were taken at 6 and at 24 hours. (iii) ‘‘Protein validation’’:
Table 1. Volunteer demographics and their just-perceptible MED
Study Skin type Sex Age MED UVA1 (J cm 2) MED UVB (mJ cm 2)
UVA1 time course I M 27 48.8 30.0
II M 21 48.8 30.0
I F 21 61.8 37.0
I F 21 61.8 23.0
Mean±SD Mþ F 22.5±2.6 55.3±6.5 30.0±4.9
UVA1 and UVB comparision I M 20 61.1 19.0
I M 21 61.1 23.0
II F 23 61.1 30.0
I F 22 61.1 23.0
II F 28 76.2 30.0
Mean±SD Mþ F 22.8±3.1 64.1±6.8 25.0±4.8
Protein validation II F 24 61.1 37.0
II F 27 61.1 37.0
I F 22 48.8 30
Mean±SD 24.3±2.5 57.0±7.1 34.7±4.0
Combined mean±SD 7I, 5II 4M, 8F 23.0±2.8 59.4±7.7 29.1±6.1
Abbreviations: F, female; M, male; MED, minimal erythema dose.
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a further three skin type I/II individuals were recruited, had UVR
sensitivity tested as above, and received UVB and UVA1
irradiations equivalent to B1MED (30 mJ cm 2 UVB and
50 J cm 2 UVA1). Biopsies were taken at 10 and 24 hours
along with an nonirradiated control biopsy.
Microarray. A single color hybridization on Agilent Whole
Human Genome Oligo Microarrays (Agilent Technologies, Wald-
bronn, Germany) (4 44 K) and bioinformatics was performed
(Milteyni Biotech, Bergisch Gladbach, Germany). Briefly, biopsies
were snap-frozen in liquid nitrogen and RNA was extracted
(Trizol, Sigma, St Louis, MO) and quality checked (Agilent 2100
bioanalyzer platform; Agilent Technologies). cRNA was pro-
duced, Cy3 labeled, and hybridized overnight (B17 hours,
65 1C) to Agilent Whole Genome Oligo Microarray chips
(4 44 K) using the Agilent Gene Expression Hybridzation Kit
(Agilent Technologies). Fluorescence signals were detected using
Agilent’s Microarray Scanner system, Agilent Feature Extraction
Software was used to process intensities. Raw intensity data were
extracted from Feature Extraction output files using Rosetta
Resolver software (Rosetta, Inpharmatics, Kirkland, WA). Back-
ground-corrected intensity values were normalized between
arrays using quantile normalization (Bolstad et al., 2003). Log2-
transformed normalized intensity values were used for sub-
sequent statistical analysis. Quality controls include comparison
of intensity profiles and a global correlation analysis. The
microarray data is deposited at NCBI GEO with accession
number GSE45493.
Quantitative real-time PCR
Total RNA was converted to cDNA (Applied Biosystems, Paisley, UK)
and quality controlled using reverse transcription PCR with b-actin as
the housekeeping gene. cDNA was visualized as characteristic bands
on a 3% agarose gel under UVR. qPCR was performed using Taqman
Gene Expression Assays (Applied Biosystems) according to the
manufacturer’s protocol with the following TaqMan DNA probes
(Applied Biosystems), FAM (6-carboxyfluorescein) labeled, and GAPDH
(Applied Biosystems) housekeeping gene, VIC labeled. Probes
used (gene name and reference no): MMP1 Hs00899658_m1,
MMP3 Hs00968305_m1, MMP9 Hs00234579_m1, MMP10
Hs00233987_m1, MMP12 Hs00899668_m1. Fold change was
calculated using the DDCT method.
Protein validation
Biopsies were placed in OCT (VWR Chemicals, Leuven, Belgium),
embedded in isopentane (VWR Chemicals, Fontenay-sous-Bois,
France), and once placed in cryovials were then frozen in liquid
nitrogen. 5–7mm sections were mounted on Superfrost plus slides and
stored at  80 1C. Sections were placed at room temperature
(10 minutes), fixed in cold acetone (10 minutes), then rinsed in
phosphate-buffered saline (PBS) for 5 minutes. (i) Immunofluorese-
cence: sections were incubated with blocking buffer for 20 minutes
(10% goat serum (DAKO, Cambridge, UK) 0.1% BSA, 0.1% Tween-
20 in PBS), washed in PBS, incubated for 90 minutes with MMP1
(1:100), MMP12 (1:400) (recognizes the proactive and active forms of
MMP12), rabbit antihuman antibodies (Abcam, UK), CD68 (1:100)
mouse antihuman antibody (Abcam, Cambridge, UK) washed in PBS,
and incubated with either Alexa Fluor goat antirabbit 555 or goat
antimouse 555 (Invitrogen, Paisley, UK) at 1:200 for 30 minutes,
counterstained with prolong gold antifade with DAPI (Molecular
Probes, Paisley, UK), coverslipped, and stored away from light.
Imaging was performed with a Zeiss Axiophot microscope (Harpen-
den, UK) and Nikon DS-U2 camera (Kingston upon Thames, UK).
Images were captured in 2560 1920 format, gain  1.00, 4 second
exposure. (ii) in situ zymography: slides were incubated with 60ml
substrate (low-gelling agarose (Sigma, Dorset, UK) (1 g dissolved in
500 ml PBS)), with four drops of 40,6-diamidino-2-phenylindole with
antigold fade (Invitrogen) and DQ-collagen 1, DQ-collagen 4, or DQ
elastin (all from Molecular Probes) at 1:10 forB18 hours in the dark.
Fluorescent imaging for fluorescein (green) and 40,6-diamidino-2-
phenylindole (blue) was performed. Images were obtained as above
and captured in 2560 1920 format, gain  1.00, 1 second expo-
sure. Analysis was performed using NIS elements BRv2 software
package as previously described (Tewari et al., 2011) after removing
background control intensity. For the spread of MMP1 and MMP12
across the epidermis, thresholding was set to capture red intensity,
and upper epidermis and lower epidermis were visually gated to give
mean intensity values corresponding to MMP amount.
Data analysis
For microarray data, bioinformatical analysis was based on normal-
ized Log2 intensities using R/Bioconductor and software packages
therein (http://www.R-project.org; http://www.bioconductor.org).
Analysis of variance with repeated measurements followed by Tukey
post hoc tests was used to test for expression differences among the
groups. The UVA1 time course was as follows: UVA1 6 hours versus
UVA1 24 hours (50 J cm 2 doses), UVA1 versus UVB at 6 hours, and
UVA1 versus UVB at 24 hours. All P-values were adjusted for
multiple testing (Benjamini and Hochberg, 1995). Differentially
expressed genes were considered if both the analysis of variance
and Tukey post hoc test P-values were p0.05 (adjusted P-value or
false discovery rate p0.3) and the expression difference was at least
twofold.
Functional analysis of candidate genes was performed using DAVID
(Database for Annotation, Visualization and Integrated Discovery)
v6.7 (Dennis et al., 2003) to identify biological clusters and GeneGo
Metacore v7 to identify key pathways. Briefly, gene ratio lists for
pooled individuals (fold changeX2, Pp0.05) from the 6- and 24-hour
biopsies were uploaded to the software program, which generated
pathway maps and P-values associating the statistical likelihood of a
sequence of genes with a particular pathway. All graphs were
generated using the Graphpad Prism v4 statistics package.
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